Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT05251480
What this trial is testing

Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People

Who this might be right for
Diabetes MellitusUlcer FootUlcer Healing+5 more
DeCell Technologies Inc. 120
Large-scale testing (Phase 3)Study completedNCT01356680
What this trial is testing

HD17 for Intermediate Stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 1,100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06106308
What this trial is testing

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

Who this might be right for
Metastatic Colorectal CancerCRCKRAS/NRAS Mutation
Cardiff Oncology 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07679997
What this trial is testing

Trilaciclib Combined With Immunochemotherapy for R/M HNSCC

Who this might be right for
Head & Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 32
Not applicableStudy completedNCT04256213
What this trial is testing

COL Immunotherapy Before Radiochimio + Ipilimumab

Who this might be right for
Cervix Cancer
ARCAGY/ GINECO GROUP 40
Testing effectiveness (Phase 2)Looking for participantsNCT06868485
What this trial is testing

Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Wayshine Biopharm, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT01757197
What this trial is testing

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Who this might be right for
Glucocorticosteroid Refractory Acute GVHD
Weill Medical College of Cornell University 2
Large-scale testing (Phase 3)Study completedNCT00910910
What this trial is testing

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Celgene 450
Testing effectiveness (Phase 2)Study completedNCT03839446
What this trial is testing

Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy

Who this might be right for
Acute Myeloid Leukemia
Robert Redner, MD 16
Testing effectiveness (Phase 2)Study completedNCT00541008
What this trial is testing

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
UNICANCER 92
Early research (Phase 1)Study completedNCT02941224
What this trial is testing

First-in-human Evaluation of the SELUTION DCB, a Novel Sirolimus Coated Balloon in Peripheral Arteries

Who this might be right for
Patients With Peripheral Artery Disease in the SFA or PA
M.A. Med Alliance S.A. 50
Large-scale testing (Phase 3)Study completedNCT00420823
What this trial is testing

Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment

Who this might be right for
Psychotic Disorders
Melbourne Health 121
Not applicableUnknownNCT05426317
What this trial is testing

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Who this might be right for
MelanomaNon Small Cell Lung CancerRenal Cancer
University Hospital, Clermont-Ferrand 100
Not applicableStudy completedNCT01244750
What this trial is testing

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Who this might be right for
Chronic Myeloid Leukemia
Bristol-Myers Squibb 1,494
Early research (Phase 1)Study completedNCT01928524
What this trial is testing

Chemotherapy for Patients With Cancer of the Stomach

Who this might be right for
First-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus or
Per Pfeiffer 34
Not applicableUnknownNCT02873013
What this trial is testing

Asia Study Group of Prostate Cancer (A-CaP Study)

Who this might be right for
Prostate Cancer
Japan Study Group of Prostate Cancer 20,000
Large-scale testing (Phase 3)Active Not RecruitingNCT04765059
What this trial is testing

Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 98
Testing effectiveness (Phase 2)Study completedNCT00937560
What this trial is testing

First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hoffmann-La Roche 190
Testing effectiveness (Phase 2)UnknownNCT06482008
What this trial is testing

HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 33
Post-approval studies (Phase 4)UnknownNCT01607918
What this trial is testing

Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy

Who this might be right for
Eradication Rates of the Two Regimens
National Taiwan University Hospital 1,300
Next Page